ImmunityBio Inc. (IBRX)
NASDAQ: IBRX
· Real-Time Price · USD
3.13
0.06 (1.95%)
At close: Jun 16, 2025, 3:59 PM
3.12
-0.19%
After-hours: Jun 16, 2025, 07:23 PM EDT
1.95% (1D)
| Bid | 3.08 |
| Market Cap | 2.76B |
| Revenue (ttm) | 31.22M |
| Net Income (ttm) | -409.1M |
| EPS (ttm) | -0.57 |
| PE Ratio (ttm) | -5.48 |
| Forward PE | -10.98 |
| Analyst | Buy |
| Ask | 3.22 |
| Volume | 6,605,184 |
| Avg. Volume (20D) | 9,128,217 |
| Open | 3.10 |
| Previous Close | 3.07 |
| Day's Range | 3.04 - 3.24 |
| 52-Week Range | 1.83 - 7.63 |
| Beta | -0.07 |
About IBRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IBRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IBRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+0.38%
ImmunityBio shares are trading higher after the co...
Unlock content with
Pro Subscription
3 weeks ago
+3.57%
ImmunityBio shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight.
